Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation

  • Muhammad Javed Iqbal
  • , Zeeshan Javed
  • , Jesús Herrera-Bravo
  • , Haleema Sadia
  • , Faiza Anum
  • , Shahid Raza
  • , Arifa Tahir
  • , Muhammad Naeem Shahwani
  • , Javad Sharifi-Rad
  • , Daniela Calina
  • , William C. Cho

Research output: Contribution to journalReview articlepeer-review

61 Scopus citations

Abstract

Recent technological advances in nanoscience and material designing have led to the development of point-of-care devices for biomolecule sensing and cancer diagnosis. In situ and portable sensing devices for bedside, diagnosis can effectively improve the patient’s clinical outcomes and reduce the mortality rate. Detection of exosomal RNAs by immuno-biochip with increased sensitivity and specificity to diagnose cancer has raised the understanding of the tumor microenvironment and many other technology-based biosensing devices hold great promise for clinical innovations to conquer the unbeatable fort of cancer metastasis. Electrochemical biosensors are the most sensitive category of biomolecule detection sensors with significantly low concentrations down to the atomic level. In this sense, this review addresses the recent advances in cancer detection and diagnosis by developing significant biological sensing devices that are believed to have better sensing potential than existing facilities.

Original languageEnglish
Article number354
JournalCancer Cell International
Volume22
Issue number1
DOIs
StatePublished - Dec 2022
Externally publishedYes

Keywords

  • Biomarkers
  • Biosensors
  • Cancer detection
  • Clinical diagnostics
  • Diagnostics
  • Oncogenes

Fingerprint

Dive into the research topics of 'Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation'. Together they form a unique fingerprint.

Cite this